Baillière's Clinical Gastroenterology
Volume 4, Issue 4, December 1990, Pages 953-968
Chemotherapy for pancreatic cancer
References (56)
- et al.
The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma
Cancer Treatment Reviews
(1975) - et al.
Combined 5-fluorouracil and supervoltage radiation therapy for locally unresectable gastrointestinal cancers
Lancet
(1969) - et al.
Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas
Journal of Clinical Oncology
(1988) - et al.
Analysis of survival by tumor response
Journal of Clinical Oncology
(1983) 5-FU/Leucovorin-biochemical modulation that works?
Oncology
(1987)Overview of clinical trials using 5-FU and leucovorin for the treatment of colorectal cancer
Cancer
(1989)- et al.
The evaluation of CT and sonographic pancreatic measurements in determining tumor response
- et al.
A Phase II study of ifosfamide (ifos) plus n-acetylcysteine (NAC) in metastatic measurable pancreatic adenocarcinoma (PC)
- et al.
Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin and mitomycin C (FAM)
Cancer Treatment Reports
(1979) - et al.
Cancer of the pancreas
Leucovorin and 5-fluorouracil as a treatment for disseminated cancer of the pancreas and unknown primary tumors
Cancer Research
(1988)
Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumors
International Journal of Clinical Pharmacology
(1976)
Phase II trial of streptozotocin, mitomycin-c and 5-fluorouracil in adenocarcinoma of the pancreas
Cancer Clinical Trials
(1980)
Phase II trial of 5-fluorouracil, adriamycin, mitomycin-C and streptozotocin (FAM-S) in pancreatic carcinoma
Cancer
(1982)
Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest Oncology Group Study
Cancer
(1983)
Treatment of malignant neoplasms of the gastrointestinal tract with a combination of 5-fluorouracil and radiation
A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma
Journal of the American Medical Association
(1985)
A Phase III evaluation of drug combinations in the therapy of advanced pancreatic cancer
Phase II study of weekly 5-fluorouracil (5FU) and folinic acid (FA) in previously untreated patients with unresectable measurable pancreatic adenocarcinoma
Phase I-II study of cisplatin (P), high-dose Ara-C (A) and caffeine (C) (CAC) in advanced adenocarcinoma of the pancreas
Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil
Cancer Research
(1981)
Interferon effects upon the adenocarcinoma 38 and HL-60 cell lines: antiproliferative responses and synergistic interactions with halogenated pyrimidine antimetabolites
Cancer Research
(1988)
Ifosfamide treatment of pancreatic cancer
Cancer Treatment Reports
(1981)
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil) and high dose radiation and 5-fluorouracil
Cancer
(1981)
Phase II studies of drug combinations in advanced pancreatic carcinoma: fluorouracil plus doxorubicin plus mitomycin-C and two regimens of streptozotocin plus mitomycin-C plus fluorouracil
Journal of Clinical Oncology
(1986)
Further evidence of effective adjuvant combined radiation; chemotherapy following curative resection of pancreatic cancer
Cancer
(1987)
Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone
Journal of the National Cancer Institute
(1988)
Ifosfamide is an inactive substance in the treatment of pancreatic carcinoma
Cancer
(1989)
Cited by (36)
Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV
2001, European Journal of Surgical OncologyRetinoids in pancreatic cancer
1999, Annals of OncologyPalliative and adjuvant regional chemotherapy in pancreatic cancer
1997, European Journal of Surgical Oncology
Copyright © 1990 Published by Elsevier Ltd.